Perceptive eClinical Launches ClinPhone 5
Perceptive eClinical, part of Perceptive Group, is pleased to announce the launch of ClinPhone 5, a ground-breaking new Randomization and…
All articles by Annaliese Watkins
Annaliese Watkins
-
-
Cervical cancer: Navigating today’s global clinical trial landscape
A new report from leading contract research organisation Novotech has shed light on the current state of play in the…
-
GITEX GLOBAL 2024: Huawei launches a series of industrial digital and intelligent transformation solutions, and flagship products
From October 14 to 18, with the theme Accelerate Industrial Digitalization and Intelligence, Huawei, as a Diamond Sponsor, is participating…
-
From operator to API: how the future of micronisation means no more compromise
Despite industry investment in large molecule drugs, demand for small molecule active pharmaceutical ingredients (API) manufacturing remains high. Driven by…
-
How new fabric technology is improving the speed and accuracy of POC diagnostics
Test strips are a significant tool in point-of-care (POC) diagnostics for blood, urine, and glucose analysis. The rising demand for…
-
Innovation in medical technical fabrics: why European filtration manufacturers are leaders in the field
European manufacturers are at the forefront of the technical textiles and nonwovens market. Reports predict that the European technical textile…
-
Managing the Covid-19 outbreak: Lessons learnt from South Korea
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral…
-
Biosimilars: The next chapter for biologics begins
Biosimilars - biologic drugs with a high degree of similarity to previously-approved innovator biologics, hit full steam in 2019, with…
-
Case studies in accelerating clinical trials in oncology
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years. As of December 2019, over 6,000…
-
Regulatory requirements for clinical trials: A comparison of Australia and the US
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international biotech companies wanting a fast…